Key result
High-frequency stimulation of ganglionated plexi during atrial fibrillation caused a 16% reduction in cycle length in adjacent pulmonary veins (166 to 139 ms, P<0.0001), which was abolished by atropine.
Why the study?
Does high-frequency stimulation of ganglionated plexi alter atrial fibrillation cycle lengths in patients with atrial fibrillation?
Does high-frequency stimulation of ganglionated plexi alter atrial fibrillation cycle lengths in patients with atrial fibrillation?
Effect estimate: 16% reduction
p-value: p=< 0.0001
Parasympathetic activation via ganglionated plexi stimulation causes heterogeneous shortening of atrial fibrillation cycle lengths, particularly in the pulmonary veins, which may promote AF drivers.
Should not alter AF ablation practice; leaves open whether GP mapping refines driver-targeted ablation.
INTRODUCTION: The intrinsic cardiac autonomic nervous system (ANS) is implicated in atrial fibrillation (AF) but little is known about its role in maintenance of the electrophysiological substrate during AF in humans. We hypothesized that ANS activation by high-frequency stimulation (HFS) of ganglionated plexi (GP) increases dispersion of atrial AF cycle lengths (AFCLs) via a parasympathetic effect. METHODS AND RESULTS: During AF in 25 patients, HFS was delivered to presumed GP sites to provoke a bradycardic vagal response and AFCL was continuously monitored from catheters placed in the pulmonary vein (PV), coronary sinus (CS), and high right atrium (HRA). A total of 163 vagal responses were identified from 271 HFS episodes. With a vagal response, the greatest reduction in AFCL was seen in the PV adjacent to the site of HFS (16% reduction, 166 ± 28 to 139 ± 26 ms, P < 0.0001) followed by the PV-atrial junction (9% reduction, 173 ± 21 to 158 ± 20 ms, P < 0.0001), followed by the rest of the atrium (3-7% reduction recorded in HRA and CS). Without a vagal response, AFCL changes were not observed. In 10 patients, atropine was administered in between HFS episodes. Before atropine administration, HFS led to a vagal response and a reduction in PV AFCL (164 ± 28 to 147 ± 26 ms, P < 0.0001). Following atropine, HFS at the same GP sites no longer provoked a vagal response, and the PV AFCL remained unchanged (164 ± 30 to 166 ± 33 ms, P = 0.34). CONCLUSIONS: Activation of the parasympathetic component of the cardiac ANS may cause heterogenous changes in atrial AFCL that might promote PV drivers.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2011) studied Atrial fibrillation (n=25). High-frequency stimulation of ganglionated plexi vs. Baseline / post-atropine was evaluated on Change in atrial fibrillation cycle length (AFCL) in the pulmonary vein adjacent to the site of stimulation (16% reduction, p=< 0.0001). High-frequency stimulation of ganglionated plexi during atrial fibrillation caused a 16% reduction in cycle length in adjacent pulmonary veins (166 to 139 ms, P<0.0001), which was abolished by atropine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: